Safety, pharmacokinetic, pharmacodynamic, and efficacy properties of orally administered APG-2449 in patients with advanced ALK (+) and ROS1 (+) non-small-cell lung cancer: a multicentre, open-label, single-arm phase 1 trial
口服APG-2449治疗晚期ALK(+)和ROS1(+)非小细胞肺癌患者的安全性、药代动力学、药效学和疗效：一项多中心、开放标签、单臂I期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103556
Ma, Yuxiang; Song, Zhengbo; Chen, Jianhua; Zhao, Yanqiu; Fang, Wenfeng; Guo, Yubiao; Dong, Yugang; Yang, Yunpeng; Wu, Gang; Fang, Jian; Lin, Xiaoyan; Li, Jundong; Huang, Yan; Zhao, Yuanyuan; Hong, Shaodong; Xue, Jinhui; Zhang, Yang; Liu, Qianwen; Yang, Chen; Xu, Liang; Yang, Yun; Xiong, Dengkun; Yang, Dajun; Zhai, Yifan; Zhang, Li; Zhao, Hongyun
